CBPO Group

CBPO Group most likely refers to China Biologic Products Holdings, a plasma-derived biopharmaceutical company historically focused on the collection of human plasma and the manufacture of plasma-based therapies in China. The company marketed products such as human albumin, intravenous immunoglobulin, and coagulation-factor products used in immune, critical care, and hematology settings. China Biologic Products Holdings was publicly traded on NASDAQ under the symbol CBPO before being taken private. Because the requested name "CBPO Group" does not appear to be the standard corporate name, this record is based on the highly likely interpretation that the query refers to the former public company associated with ticker CBPO.